Furthermore, SMYD3 is significantly associated with the proliferation, invasion, cell cycle regulation, prognosis, and recurrence of malignant tumors, such as liver, breast, and prostate cancers [54–58]. This evidence concerns the gene SMYD3 and prostate carcinoma.